Table 1.
Laboratory findings on admission
| Hematology | Normal range | |
|---|---|---|
| White blood cells* |
13700/mm3 |
3300 – 9000/mm3 |
| Red blood cells |
467 × 104/mm3 |
430 – 570 × 104/mm3 (Male) |
| Hemoglobin |
13.6 g/dl |
13.5 – 17.5 g/dl (Male) |
| Hematocrit |
41.3% |
39.7 – 52.4% (Male) |
| Platelets |
29.3 × 104/mm3 |
14.0 – 34.0 × 104/mm3 |
|
Differential white blood cell count
|
|
|
| Segmented neutrophils* |
70.0% |
34.0 – 70.0% |
| Band cells, stab cells* |
15.0% |
1.0 – 7.0% |
| Eosinophils |
1.0% |
0 - 8.0% |
| Monocytes |
5.0% |
2.0 – 10.0% |
| Lymphocytes* |
9.0% |
18.0 – 49.0% |
|
Biochemistry
|
|
|
| Total protein* |
6.2 g/dl |
6.7 – 8.3 g/dl |
| Albumin* |
3.4 g/dl |
3.8 – 5.2 g/dl |
| AST* |
2660 IU/l |
10 – 40 IU/l |
| ALT* |
2037 IU/l |
5 – 45 IU/l |
| LDH* |
3307 IU/l |
120 – 240 IU/l |
| ALP* |
793 IU/l |
100 – 325 IU/l |
| γ-GTP* |
197 IU/l |
10 – 50 IU/l |
| Total bilirubin* |
1.7 mg/dl |
0.2 – 1.2 mg/dl |
| Direct bilirubin* |
1.0 mg/dl |
0 – 0.4 mg/dl |
| CPK* |
978 IU/l |
60 – 270 IU/l |
| CPK-MB* |
231 ng/ml |
< 5.2 ng/ml |
| Blood urea nitrogen* |
63.4 mg/dl |
8.0 – 20.0 mg/dl |
| Creatinine* |
3.01 mg/dl |
0.61 - 1.04 mg/dl |
| Sodium |
141 mEq/l |
135 – 145 mEq/l |
| Potassium |
3.8 mEq/l |
3.5 – 5.0 mEq/l |
| Chloride |
106 mEq/l |
98 – 108 mEq/l |
| Calcium |
8.4 mg/dl |
8.4 – 10.4 mg/dl |
| Phosphorus |
3.1 mg/dl |
2.5 – 4.5 mg/dl |
| Glucose |
99 mg/dl |
70 – 109 mg/dl |
| C-reactive protein* |
5.50 mg/dl |
< 0.30 mg/dl |
| BNP* |
4806 pg/ml |
< 18.4 pg/ml |
| Troponin-I* |
28.4 ng/ml |
< 0.04 ng/ml |
|
Blood coagulation test
|
|
|
| PT-INR* |
2.19 |
0.85-1.15 |
|
Serology
|
|
|
| HBsAg |
Negative |
Negative |
| HCV-RNA |
Negative |
Negative |
| IgM anti-HAV Ab |
Negative |
Negative |
| Anti-HIV Ab | Negative | Negative |
*These values are outside the normal ranges.
Abbreviations:AST aspartate aminotransferase, ALT alanine aminotransferase, LDH lactate dehydrogenase, ALP alkaline phosphatase, γ-GTP gamma-glutamyltranspeptidase, CPK creatine phosphokinase, BNP brain natriuretic peptide, PT-INR international normalized ratio of prothrombin time, APTT activated partial thromboplastin time.